18,000+ cases of Foundation Medicine (FMI) Single Nucleotide Variants Now Available in the NCI Genomic Data Commons (GDC)

  • Date Posted:
    • October 24, 2017
  • Categories:

FMI has provided the Genomic Data Commons (GDC) with genomic profiling data from approximately 18,000 adult patients with a diverse array of cancers that underwent genomic profiling using FoundationOne®, FMI's commercially available, comprehensive genomic profiling assay. FMI routinely analyzes cancer specimens using the advanced sequencing technology of FoundationOne. The GDC modified FMI’s patient data with a LiftOver pipeline to harmonize genomic profiles with the GRCh38 reference genome.